CD28 on CD39+ secreting CD4 regulatory T cell and CD3 on CD39+ CD8+ T cell may affect the pathogenesis and development of SS through adenosine (and its derivatives) or IFN, which needs to be clarified by validation and functional evaluation experiments. The gene discussed is ENTPD1; the disease is synovial sarcoma.